By Pia Rivera
Revive Therapeutics Ltd. (“Revive” or the “Company”) (TSX VENTURE:RVV)(OTCQB:RVVTF), a company focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and pharmaceutical sectors, today announced that Mr. Bernie Doyle will join the Company as a Technical Advisor to support the development of the
By Jocelyn Aspa
USA Technologies, Avid Technology, Evolving Systems, Internap, and JMU were last week’s top gainers.
Ekso Bionics Holdings, Senomyx, ChromaDex, Sierra Oncology and Novelion Therapeutics topped last week’s NASDAQ biotech stock list.
The gold price edged higher on Friday as the US dollar eased. Meanwhile, silver was on track for a weekly increase and copper was down for the week.
By Pia Rivera
TerrAscend Corp. (CSE: TER) (“TerrAscend” or the “Company”) is pleased to announce that it has entered into subscription agreements with funds advised by JW Asset Management LLC (“JW Funds”), Canopy Growth Corporation (“Canopy Growth”) and Canopy Rivers Corporation (“Canopy Rivers”) pursuant to which the investors will acquire from TerrAscend, on
360 Blockchain Strategic Advisor Jeff Koyen sees many different applications for blockchain, and the company will be investing expertise and capital in a few of these.
By Micha Boon
Eyecarrot Innovations Corp. (TSXV:EYC | OTCQB : EYCCF), is pleased to announce that it proposes to increase the size of its previously announced non-brokered private placement (the “Offering”), such that it will now issue up to (i) 16,000,000 units (“Unit”); each Unit will consist of one common share of the
WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, and Van der Pop (“VdP”), one of North America’s leading female-focused cannabis brands together with parent TS BrandCo, announced today that they have signed a definitive agreement to distribute two branded strains of cannabis under
Zomedica Pharmaceuticals announced its stock will begin trading on the NYSE American listing on November 21, while retaining its TSXV stock.
Referenced as a connoisseur of the blockchain world, 360 Blockchain (CSE: CODE; FWB: C5B; OTC PINK: BKLLF) Strategic Advisor Jeff Koyen was interviewed to help provide insight on the technology and the company’s approach to it.
Q BioMed Inc. (OTCQB: QBIO) congratulates our collaborative research partner and licensor, Mannin Research Inc., on receiving R&D funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to initiate work on a Tie2-activating biologic for the treatment of glaucoma.
Investors who value long-term growth look to diversified cannabis stocks.
Collegium Pharmaceutical, Depomed, Xoma, ChromaDex and Ophthotech topped last week’s NASDAQ biotech stock list.
By Micha Boon
Eyecarrot Innovations Corp . (TSXV:EYC) (the “Company”), is pleased to announce that it seeks to complete a non-brokered private placement of 10,000,000 units of the Company (the “Units”) at a price of $0.10 per Unit for a total of $1,000,000 (the “Financing”). Each Unit will consist of one common share
CBD is improving health and driving the cannabis industry. Know more about its health benefits and opportunities for CBD-based companies.